Skin Diseases, Bacterial

Open Access

Clinical Therapeutics
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
William O'Riordan, Courtney Tiffany, Nicole Scangarella-Oman, Caroline Perry, Mohammad Hossain, Teri Ashton, Etienne Dumont
Clinical Therapeutics
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials
Taylor Sandison, Carisa De Anda, Edward Fang, Anita F. Das, Philippe Prokocimer
Susceptibility
In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections
Karen M. Amsler, Todd A. Davies, Wenchi Shang, Michael R. Jacobs, Karen Bush
Clinical Therapeutics
Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria
Gary J. Noel, Richard S. Strauss, Karen Amsler, Markus Heep, Rienk Pypstra, Joseph S. Solomkin
Clinical Therapeutics
Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections
A. K. Meagher, J. A. Passarell, B. B. Cirincione, S. A. Van Wart, K. Liolios, T. Babinchak, E. J. Ellis-Grosse, P. G. Ambrose
Clinical Therapeutics
Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study
Martin E. Stryjewski, Vivian H. Chu, William D. O'Riordan, Brian L. Warren, Lala M. Dunbar, David M. Young, Marc Vallée, Vance G. Fowler, Joel Morganroth, Steven L. Barriere, Michael M. Kitt, G. Ralph Corey
and for the FAST 2 Investigator Group
LETTERS TO THE EDITOR
Improved Outcomes with Linezolid for Methicillin-Resistant Staphylococcus aureus Infections: Better Drug or Reduced Vancomycin Susceptibility?
Benjamin P. Howden, Patrick G. P. Charles, Paul D. R. Johnson, Peter B. Ward, M. Lindsay Grayson
Clinical Therapeutics
Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam
Johannes Breedt, Jüri Teras, Janis Gardovskis, Frans Jacobus Maritz, Tiit Vaasna, Douglas Patrick Ross, Martine Gioud-Paquet, Nathalie Dartois, Evelyn J. Ellis-Grosse, Evan Loh
and for the Tigecycline 305 cSSSI Study Group
Experimental Therapeutics
Establishment of a Superficial Skin Infection Model in Mice by Using Staphylococcus aureus and Streptococcus pyogenes
Elisabeth Kugelberg, Tobias Norström, Thomas K. Petersen, Tore Duvold, Dan I. Andersson, Diarmaid Hughes
Susceptibility
In Vitro Activity and Killing Effect of Citropin 1.1 against Gram-Positive Pathogens Causing Skin and Soft Tissue Infections
Andrea Giacometti, Oscar Cirioni, Wojciech Kamysz, Carmela Silvestri, Maria Simona Del Prete, Alberto Licci, Giuseppina D'Amato, Jerzy Łukasiak, Giorgio Scalise

Main menu

User menu

Search

Skin Diseases, Bacterial

Pages